GSK3145095 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as an inhibitor of the RIP1 kinase enzyme, which plays a significant role in regulating inflammation and cell death. By targeting this enzyme, GSK3145095 has the potential to modulate inflammatory responses and apoptosis in cancer cells, making it a promising candidate for the development of treatments for various types of cancer. Researchers are particularly interested in its application for cancers where inflammation and cell survival pathways are critical to disease progression. Its use in preclinical studies helps in understanding the underlying mechanisms of cancer and in evaluating its efficacy and safety as a therapeutic agent.